What is a stock summary page? Click here for an overview.
Business Description
Tien Liang BioTech Co Ltd
NAICS : 325412
ISIN : TW0004127006
Description
Tien Liang BioTech Co Ltd develops and supplies chemicals, pharmaceutical, and Chinese herbs. It offers products for the treatment of intestinal track disease, osteoporosis, eye drops, cholesterin content, angiosclerosis, and hepatic diseases.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.38 | |||||
| Equity-to-Asset | 0.54 | |||||
| Debt-to-Equity | 0.72 | |||||
| Debt-to-EBITDA | 13.54 | |||||
| Interest Coverage | 0.19 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 2.85 | |||||
| Beneish M-Score | 4.76 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -12.3 | |||||
| 3-Year EBITDA Growth Rate | -26.1 | |||||
| 3-Year EPS without NRI Growth Rate | -36.6 | |||||
| 3-Year FCF Growth Rate | -0.3 | |||||
| 3-Year Book Growth Rate | 4.9 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 56.37 | |||||
| 9-Day RSI | 51.39 | |||||
| 14-Day RSI | 49.08 | |||||
| 3-1 Month Momentum % | 3.76 | |||||
| 6-1 Month Momentum % | 16.28 | |||||
| 12-1 Month Momentum % | 29.87 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.61 | |||||
| Quick Ratio | 0.46 | |||||
| Cash Ratio | 0.32 | |||||
| Days Inventory | 159.28 | |||||
| Days Sales Outstanding | 22.07 | |||||
| Days Payable | 34.79 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.34 | |||||
| Dividend Payout Ratio | 1.92 | |||||
| Forward Dividend Yield % | 1.34 | |||||
| 5-Year Yield-on-Cost % | 1.34 | |||||
| Shareholder Yield % | -4.45 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 59.69 | |||||
| Operating Margin % | 0.15 | |||||
| Net Margin % | 3.04 | |||||
| FCF Margin % | 11.47 | |||||
| ROE % | 2.41 | |||||
| ROA % | 1.61 | |||||
| ROIC % | 0.09 | |||||
| 3-Year ROIIC % | -8.68 | |||||
| ROC (Joel Greenblatt) % | 4.28 | |||||
| ROCE % | 3.2 | |||||
| Years of Profitability over Past 10-Year | 5 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 139.42 | |||||
| PE Ratio without NRI | 139.42 | |||||
| Price-to-Owner-Earnings | 31.15 | |||||
| PS Ratio | 4.29 | |||||
| PB Ratio | 3.47 | |||||
| Price-to-Tangible-Book | 3.48 | |||||
| Price-to-Free-Cash-Flow | 38.32 | |||||
| Price-to-Operating-Cash-Flow | 35.03 | |||||
| EV-to-EBIT | 118.75 | |||||
| EV-to-EBITDA | 75.37 | |||||
| EV-to-Revenue | 4.98 | |||||
| EV-to-FCF | 44.04 | |||||
| Price-to-GF-Value | 3.31 | |||||
| Price-to-Projected-FCF | 2.99 | |||||
| Price-to-Median-PS-Value | 3.74 | |||||
| Price-to-Graham-Number | 4.64 | |||||
| Earnings Yield (Greenblatt) % | 0.84 | |||||
| FCF Yield % | 2.59 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Tien Liang BioTech Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 385.206 | ||
| EPS (TTM) (NT$) | 0.26 | ||
| Beta | -0.04 | ||
| 3-Year Sharpe Ratio | 0.66 | ||
| 3-Year Sortino Ratio | 2.39 | ||
| Volatility % | 106.71 | ||
| 14-Day RSI | 49.08 | ||
| 14-Day ATR (NT$) | 1.453826 | ||
| 20-Day SMA (NT$) | 37.3675 | ||
| 12-1 Month Momentum % | 29.87 | ||
| 52-Week Range (NT$) | 27.05 - 47.8 | ||
| Shares Outstanding (Mil) | 45.76 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Tien Liang BioTech Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Tien Liang BioTech Co Ltd Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Tien Liang BioTech Co Ltd Frequently Asked Questions
What is Tien Liang BioTech Co Ltd(ROCO:4127)'s stock price today?
The current price of ROCO:4127 is NT$36.25. The 52 week high of ROCO:4127 is NT$47.80 and 52 week low is NT$27.05.
When is next earnings date of Tien Liang BioTech Co Ltd(ROCO:4127)?
The next earnings date of Tien Liang BioTech Co Ltd(ROCO:4127) is .
Does Tien Liang BioTech Co Ltd(ROCO:4127) pay dividends? If so, how much?
The Dividend Yield %  of Tien Liang BioTech Co Ltd(ROCO:4127) is 1.34% (As of Today), Highest Dividend Payout Ratio of Tien Liang BioTech Co Ltd(ROCO:4127) was 1.92. The lowest was 0.65. And the median was 1.29. The  Forward Dividend Yield % of Tien Liang BioTech Co Ltd(ROCO:4127) is 1.34%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers